Indivior Pharmaceuticals, Inc. INDV Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's other non-current liabilities?
- Indivior Pharmaceuticals, Inc. (INDV) reported other non-current liabilities of $21M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's other non-current liabilities changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's other non-current liabilities increased by 23.5% year-over-year, from $17M to $21M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's other non-current liabilities?
- Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc. 's other non-current liabilities has grown at a -17.7% compound annual growth rate (CAGR), from $31M to $21M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.